SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ZERZA ARMIN (Last) (First) (Middle) C/O ACTIVISION BLIZZARD, INC. 3100 OCEAN PARK BOULEVARD (Street) SANTA MONICA CA 90405 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Activision Blizzard, Inc. [ ATVI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Financial Officer
	3. Date of Earliest Transaction (Month/Day/Year) 11/04/2021
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.000001 per share	11/04/2021		A		10,992(1)	A	$0	173,430	D
Common Stock, par value $0.000001 per share	11/04/2021		A		5,496(2)	A	$0	178,926	D
Common Stock, par value $0.000001 per share	11/04/2021		A		5,496(3)	A	$0	184,422	D
Common Stock, par value $0.000001 per share	11/04/2021		A		13,748(4)	A	$0	198,170	D
Common Stock, par value $0.000001 per share	11/04/2021		A		6,874(5)	A	$0	205,044	D
Common Stock, par value $0.000001 per share	11/04/2021		A		6,874(6)	A	$0	211,918(7)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant was for 10,992 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 13,740 shares of the Company's common stock. These restricted stock units will vest on March 30, 2025, based upon the level of achievement measured by reference to the Company's cumulative earnings per share growth for the years 2022, 2023, and 2024.

2. This grant was for 5,496 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 6,870 shares of the Company's common stock. These restricted stock units will vest on March 30, 2025, based upon the level of performance measured by reference to the Company's cumulative operating income for the years 2022, 2023, and 2024.

3. This grant was for 5,496 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 6,870 shares of the Company's common stock. These restricted stock units will vest on March 30, 2025, based upon the level of performance measured by reference to the Company's total shareholder return for the years ending 2022, 2023, and 2024.

4. This grant was for 13,748 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 17,186 shares of the Company's common stock. These restricted stock units will vest in three equal tranches on each of March 30, 2023, March 30, 2024, and March 30, 2025, in each case, based upon the level of performance measured by reference to the Company's earnings per share growth objective, as set forth in the Company's annual operating plan for the prior year.

5. This grant was for 6,874 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 8,593 shares of the Company's common stock. These restricted stock units will vest in three equal tranches on each of March 30, 2023, March 30, 2024, and March 30, 2025, in each case, based upon the level of performance measured by reference to the Company's operating income objective, as set forth in the Company's annual operating plan for the prior year.

6. This grant was for 6,874 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number reported assumes target performance; maximum performance would result in the release of 8,593 shares of the Company's common stock. These restricted stock units will vest in three equal tranches on each of March 30, 2023, March 30, 2024, and March 30, 2025, in each case, based on the performance level measured by reference to the Company's total shareholder return for the prior year.

7. Following the transactions reported on this Form 4, Mr. Zerza held (a) 185,596 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock, and (b) 26,322 restricted share units, each representing the right to receive one share of the Company's common stock. The actual number of aggregate shares earned in connection with the performance-vesting restricted stock units will depend on actual performance and will range from 0 to 231,277 shares of the Company's common stock. The number of performance-vesting restricted stock units assumes, as previously disclosed, target performance for each performance-vesting restricted stock unit grant.

Remarks:

	/s/ Armin Zerza	11/08/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.